Literature DB >> 18463221

Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.

Peggy L Carver1, Shu-Wen Lin, Daryl D DePestel, Duane W Newton.   

Abstract

In patients with Staphylococcus aureus bacteremia, intervention by infectious disease clinical pharmacists on the basis of the results of tests for mecA resulted in a 25.4-h reduction in the time to optimal antimicrobial therapy, from 64.7 +/- 36.8 to 39.3 +/- 15.5 h (P = 0.002), which may result in decreased mortality.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18463221      PMCID： PMC2446910          DOI： 10.1128/JCM.00801-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program.

Authors:  Ann Huletsky; Pierre Lebel; Francois J Picard; Marthe Bernier; Martin Gagnon; Nathalie Boucher; Michel G Bergeron
Journal:  Clin Infect Dis       Date:  2005-03-04       Impact factor: 9.079

2.  Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Martin E Stryjewski; Lynda A Szczech; Daniel K Benjamin; Jula K Inrig; Zeina A Kanafani; John J Engemann; Vivian H Chu; Maria J Joyce; L Barth Reller; G Ralph Corey; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2006-12-08       Impact factor: 9.079

3.  Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

Authors:  Thomas P Lodise; Peggy S McKinnon; Linda Swiderski; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2003-05-20       Impact factor: 9.079

4.  A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.

Authors:  Feng-Yee Chang; Brent B MacDonald; James E Peacock; Daniel M Musher; Patricia Triplett; Joseph M Mylotte; Alice O'Donnell; Marilyn M Wagener; Victor L Yu
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889
  4 in total
  17 in total

Review 1.  Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes.

Authors:  K Z Vardakas; F I Anifantaki; K K Trigkidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-02       Impact factor: 3.267

2.  Unanticipated Multiplex PCR-Based Identification of Polymicrobial Blood Culture Resulting in Earlier Isolation, Determination of Susceptibilities, and Optimization of Clinical Care.

Authors:  Tristan Timbrook; M Sean Boger; Lisa L Steed; John M Hurst
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

3.  Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing.

Authors:  Ritu Banerjee; Christine B Teng; Scott A Cunningham; Sherry M Ihde; James M Steckelberg; James P Moriarty; Nilay D Shah; Jayawant N Mandrekar; Robin Patel
Journal:  Clin Infect Dis       Date:  2015-07-20       Impact factor: 9.079

Review 4.  [Advances in diagnostic microbiology : Opportunities and limitations].

Authors:  F P Maurer; M Hentschke; H Rohde
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-03-24       Impact factor: 0.840

Review 5.  De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.

Authors:  J Daniel Markley; Shaina Bernard; Gonzalo Bearman; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

6.  Individualized Approaches Are Needed for Optimized Blood Cultures.

Authors:  Ritu Banerjee; Volkan Özenci; Robin Patel
Journal:  Clin Infect Dis       Date:  2016-08-23       Impact factor: 9.079

7.  A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

Authors:  R Murri; F Taccari; T Spanu; T D'Inzeo; I Mastrorosa; F Giovannenze; G Scoppettuolo; G Ventura; C Palazzolo; M Camici; S Lardo; B Fiori; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-19       Impact factor: 3.267

8.  Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients.

Authors:  Stacy G Beal; Jane Ciurca; Geremy Smith; Jeffrey John; Francesca Lee; Christopher D Doern; Rita M Gander
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

9.  Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.

Authors:  David T Nguyen; Ellen Yeh; Sharon Perry; Robert F Luo; Benjamin A Pinsky; Betty P Lee; Deepak Sisodiya; Ellen Jo Baron; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

10.  Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing.

Authors:  Jerod L Nagel; Angela M Huang; Anjly Kunapuli; Tejal N Gandhi; Laraine L Washer; Jessica Lassiter; Twisha Patel; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-05-28       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.